The company's purpose is to invest in companies in the fields of biotechnology, medical technology, diagnostics and healthcare information technology worldwide, through the purchase, sale and holding of participations, the granting of loans and the management and financing of these companies. The company may establish branches and subsidiaries in Switzerland and/or abroad and participate in other companies in Switzerland and/or abroad, acquire, hold, encumber and dispose of real estate and intellectual property rights in Switzerland and/or abroad, and conduct all commercial, financial or other business that is directly or indirectly related to the company's purpose. Furthermore, the company may grant loans or other financing to its direct or indirect shareholders and their direct or indirect subsidiaries, as well as to third parties, for consideration or free of charge, and provide security of any kind for the liabilities of such persons or group companies, including guarantees, pledges and fiduciary transfers of the company's assets. In addition, it may engage in liquidity balancing/net liquidity centralization (cash pooling) with group companies, including periodic balance adjustments (balancing), without consideration, on preferential terms, interest-free, without the intention of generating profits for the company, and assuming bulk risks.